1

2 Silvia Quadrelli Fundación Sanatorio Güemes Hospital Británico de Buenos Aires. Es el MMF el tratamiento de las ILD-ETC? NO

3 [email protected] 2

4 3

5 4

6 not so easy

7 6

8 7 El EUSTAR (n = 3656 SSc) mostró IL D en n 53% de enfermedad difusa y 35% de limitada ILD explica 16% de las muertes Ciclofosfamida importantes efectos adversos CFM x 6 meses seguida de aza por al menos dos años advirtiendo de los riesgos

9 [email protected] 8 -25

10

11 [email protected] 10

12 [email protected] 11

13 [email protected] 12

14 [email protected] 13

15 [email protected] 14

16 [email protected] 15

17 [email protected] 16

18 [email protected] 17

19 [email protected] 18

20 [email protected] 19

21 [email protected] 20

22 [email protected] 21

23 [email protected] 22

24 [email protected] 23

25 [email protected] 24

26 [email protected] 25

27 [email protected] 26

28 [email protected] 27

29 [email protected] 28 NO

30 [email protected] 29

31 [email protected] 30